Aer Therapeutics CEO Jim Shaffer (L) and founder John Fahy
April 13, 2023 07:00 AM EDT
Financing
Startups

Trio of VCs launch­es Gael­ic-in­spired Aer Ther­a­peu­tics with $36M to prove it­self in COPD around 2025

Kyle LaHucik

Senior Reporter

North Car­oli­na biotech Aer Ther­a­peu­tics emerged Thurs­day with $36 mil­lion in ven­ture cap­i­tal fund­ing to run a Phase I study in Aus­tralia this year and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

Eu­ro­pean drug reg­u­la­tor re­vers­es opin­ion on Ei­sai and Bio­gen's Alzheimer's drug

BeiGene will re­brand to BeOne Med­i­cines, drop­ping name's link to Chi­na roots

Mer­ck buys in­to PD-1/VEGF space as Sum­mit comes for Keytru­da

No­vo Nordisk to phase out its pro­duc­tion of hu­man in­sulin pens glob­al­ly

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times